We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
10 hedge funds and large institutions have $170K invested in Decoy Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more funds holding
Funds holding: 8 → 10 (+2)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
25% less capital invested
Capital invested by funds: $227K → $170K (-$57K)
Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$17K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$8.98K |
| 4 |
Renaissance Technologies
New York
|
+$998 |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$94.8K |
| 2 |
HKAM
Horizon Kinetics Asset Management
New York
|
-$998 |